USD
$0.00
(0.00%
)At Close (As of Sep 3, 2025)
$98.25M
Market Cap
-
P/E Ratio
-0.06
EPS
$1.84
52 Week High
$0.50
52 Week Low
LIFE SCIENCES
Sector
Field | Value (CAD) |
---|---|
Gross Profit | $192K |
Total Revenue | $872K |
Cost Of Revenue | $680K |
Costof Goods And Services Sold | $680K |
Operating Income | -$9.6M |
Selling General And Administrative | $7.9M |
Research And Development | $466K |
Operating Expenses | $9.8M |
Investment Income Net | - |
Net Interest Income | $5.5K |
Interest Income | $102K |
Interest Expense | $91K |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $600K |
Income Before Tax | -$10M |
Income Tax Expense | - |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$10M |
Comprehensive Income Net Of Tax | - |
Ebit | -$9.9M |
Ebitda | -$9.3M |
Net Income | -$10M |
Field | Value (CAD) |
---|---|
Total Assets | $18M |
Total Current Assets | $4.4M |
Cash And Cash Equivalents At Carrying Value | $121K |
Cash And Short Term Investments | $121K |
Inventory | $888K |
Current Net Receivables | $1.2M |
Total Non Current Assets | $14M |
Property Plant Equipment | - |
Accumulated Depreciation Amortization Ppe | - |
Intangible Assets | - |
Intangible Assets Excluding Goodwill | - |
Goodwill | - |
Investments | - |
Long Term Investments | - |
Short Term Investments | - |
Other Current Assets | $2.2M |
Other Non Current Assets | - |
Total Liabilities | $3.6M |
Total Current Liabilities | $3.5M |
Current Accounts Payable | $2M |
Deferred Revenue | - |
Current Debt | - |
Short Term Debt | $519K |
Total Non Current Liabilities | $162K |
Capital Lease Obligations | $334K |
Long Term Debt | - |
Current Long Term Debt | $347K |
Long Term Debt Noncurrent | - |
Short Long Term Debt Total | $680K |
Other Current Liabilities | $439K |
Other Non Current Liabilities | - |
Total Shareholder Equity | $15M |
Treasury Stock | - |
Retained Earnings | -$84M |
Common Stock | $89M |
Common Stock Shares Outstanding | $103M |
Field | Value (CAD) |
---|---|
Operating Cashflow | -$6.3M |
Payments For Operating Activities | - |
Proceeds From Operating Activities | - |
Change In Operating Liabilities | - |
Change In Operating Assets | - |
Depreciation Depletion And Amortization | $600K |
Capital Expenditures | $1.4K |
Change In Receivables | - |
Change In Inventory | $397K |
Profit Loss | - |
Cashflow From Investment | $359K |
Cashflow From Financing | $2.5M |
Proceeds From Repayments Of Short Term Debt | - |
Payments For Repurchase Of Common Stock | - |
Payments For Repurchase Of Equity | - |
Payments For Repurchase Of Preferred Stock | - |
Dividend Payout | - |
Dividend Payout Common Stock | - |
Dividend Payout Preferred Stock | - |
Proceeds From Issuance Of Common Stock | - |
Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
Proceeds From Issuance Of Preferred Stock | - |
Proceeds From Repurchase Of Equity | - |
Proceeds From Sale Of Treasury Stock | - |
Change In Cash And Cash Equivalents | - |
Change In Exchange Rate | - |
Net Income | -$10M |
Field | Value (CAD) |
---|---|
Gross Profit | $192K |
Total Revenue | $872K |
Cost Of Revenue | $680K |
Costof Goods And Services Sold | $680K |
Operating Income | -$9.6M |
Selling General And Administrative | $7.9M |
Research And Development | $466K |
Operating Expenses | $9.8M |
Investment Income Net | - |
Net Interest Income | $5.5K |
Interest Income | $102K |
Interest Expense | $91K |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $600K |
Income Before Tax | -$10M |
Income Tax Expense | - |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$10M |
Comprehensive Income Net Of Tax | - |
Ebit | -$9.9M |
Ebitda | -$9.3M |
Net Income | -$10M |
Sector: LIFE SCIENCES
Industry: MISCELLANEOUS CHEMICAL PRODUCTS
None